Connect with us
In 2025 Poland, legal medical cannabis has clear quality, safety, and dosing advantages over unpredictable illegal street product, making therapeutic use more sensible than recreational smoking....
In 2025, medical cannabis use in Poland stabilized and matured. Pharmacies dispensed over 5 tons to 105,000 patients through 537,000 prescriptions. Growth slowed after rapid expansion...
A new US appropriations bill effectively redefining hemp tightens THC limits, bans synthetic cannabinoids, and could dismantle much of the current hemp-derived products market. Critics call...
The International Congress on Industrial Hemp and Medicinal Cannabis gathered over 1,500 participants from diverse sectors in Argentina. Led by Drs. Kochen and Morante, it featured...
Medical cannabis in Colombia is gaining traction, with 21% open to its use. Strict regulations require prescriptions and INVIMA certification for quality assurance. Patients can access...
Poland now requires in-person doctor visits for medical cannabis prescriptions, replacing online approvals. This change, effective November 7th, 2024, enhances patient safety but reduces prescription numbers....
Poland's medical cannabis market is clearly on a strong growth trajectory, but the reliance on imports presents major challenges. The sharp increase in demand reflects not...
Spain's medical cannabis production grew 42.5% in 2024, reaching 51.3 tons, despite lacking domestic regulation. Licensed for export, the sector generates €500 million annually, driven by...
New regulations in Poland require in-person doctor visits for medical cannabis prescriptions, leading to a sharp drop from 68,000 in October 2024 to 28,000 by December....
Poland's Ministry of Health has restricted medical cannabis prescriptions through teleconsultations due to concerns over system abuse. Now, patients must have in-person consultations for cannabis-based treatments....